Atrial Fibrillation, Stroke, and Mortality Rates After Transcatheter Aortic Valve Implantation

Transcatheter aortic valve implantation (TAVI) is considered a suitable treatment for patients with severe symptomatic aortic stenosis and high operative risk. Our aim was to evaluate the effect of preprocedural and new-onset atrial fibrillation (NOAF) on mortality and stroke in patients who underwent TAVI. We performed a single-center study of 380 consecutive patients enrolled to a TAVI registry. NOAF was defined as postprocedural atrial fibrillation (AF) occurring within 30 days after the procedure.

Source: The American Journal of Cardiology - September 25, 2014 Category: Cardiology Authors: Lior Yankelson, Arie Steinvil, Liron Gershovitz, Eran Leshem-Rubinow, Ariel Furer, Sami Viskin, Gad Keren, Shmuel Banai, Ariel Finkelstein Tags: Valvular Heart Disease Source Type: research